Advancements in Drug Delivery Systems for the Treatment of Sarcopenia: An Updated Overview
- PMID: 39409095
- PMCID: PMC11476378
- DOI: 10.3390/ijms251910766
Advancements in Drug Delivery Systems for the Treatment of Sarcopenia: An Updated Overview
Abstract
Since sarcopenia is a progressive condition that leads to decreased muscle mass and function, especially in elderly people, it is a public health problem that requires attention from researchers. This review aims to highlight drug delivery systems that have a high and efficient therapeutic potential for sarcopenia. Current as well as future research needs to consider the barriers encountered in the realization of delivery systems, such as the route of administration, the interaction of the systems with the aggressive environment of the human body, the efficient delivery and loading of the systems with therapeutic agents, and the targeted delivery of therapeutic agents into the muscle tissue without creating undesirable adverse effects. Thus, this paper sets the framework of existing drug delivery possibilities for the treatment of sarcopenia, serving as an inception point for future interdisciplinary studies.
Keywords: aging of muscle; drug delivery; muscles; sarcopenia; treatment.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Emerging Therapeutic Strategies in Sarcopenia: An Updated Review on Pathogenesis and Treatment Advances.Int J Mol Sci. 2024 Apr 12;25(8):4300. doi: 10.3390/ijms25084300. Int J Mol Sci. 2024. PMID: 38673885 Free PMC article. Review.
-
Advances in sarcopenia: mechanisms, therapeutic targets, and intervention strategies.Arch Pharm Res. 2024 Apr;47(4):301-324. doi: 10.1007/s12272-024-01493-2. Epub 2024 Apr 9. Arch Pharm Res. 2024. PMID: 38592582 Review.
-
Sarcopenia: Molecular Pathways and Potential Targets for Intervention.Int J Mol Sci. 2020 Nov 22;21(22):8844. doi: 10.3390/ijms21228844. Int J Mol Sci. 2020. PMID: 33266508 Free PMC article. Review.
-
Aging of the endocrine system and its potential impact on sarcopenia.Eur J Intern Med. 2016 Nov;35:10-15. doi: 10.1016/j.ejim.2016.07.017. Epub 2016 Jul 30. Eur J Intern Med. 2016. PMID: 27484963 Review.
-
Sarcopenia: pharmacology of today and tomorrow.J Pharmacol Exp Ther. 2012 Dec;343(3):540-6. doi: 10.1124/jpet.112.191759. Epub 2012 Aug 28. J Pharmacol Exp Ther. 2012. PMID: 22929991 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources